News

Newsletter

7 de April de 2020

Emergency measures derived from Covid-19: Brazilian Senate approves the postponement of Brazilian Data Protection Regulation

Last Friday, the Brazilian Senate deliberated about the Bill of Law no. 1,179/2020, which sets forth the Emergency and Transitory Legal Regime of relations in private law, based on the New Coronavirus (Covid-19) pandemic. Among its sections, there are two specific provisions that change the scenario of privacy and data protection in Brazil: the postponement of the effectiveness of Law no. 13,709/2020 (the Brazilian Data Protection Regulation – “LGPD”) to January 2021 and the application of the administrative sanctions to August of the same year. Originally, both would be applicable as of August 2020.
 
For further information, click below to access our full newsletter.
Back

Last related news

9 de December de 2025

Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

For years, the most common form of software piracy involved downloading cracked or unauthorized versions from websites offering them for free. Although Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

  • Kasznar Leonardos
  • Ler notícia

    25 de November de 2025

    Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

    Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

  • Kasznar Leonardos
  • Ler notícia

    13 de November de 2025

    ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

    The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
  • Ler notícia